| 2011 |
MCU (CCDC109A) was identified as the pore-forming component of the mitochondrial calcium uniporter. MCU forms oligomers in the mitochondrial inner membrane, physically interacts with MICU1, and resides within a large molecular weight complex. Silencing MCU severely abrogates mitochondrial Ca2+ uptake without affecting respiration or membrane potential. Two predicted transmembrane helices are separated by a conserved linker facing the intermembrane space; acidic residues in this linker are required for full activity, and an S259A mutation confers resistance to Ru360. |
Whole-genome phylogenetic profiling, genome-wide RNA co-expression, organelle-wide protein co-expression, RNAi silencing in cells and mouse liver, Co-IP, transmembrane topology analysis, site-directed mutagenesis, pharmacological inhibition |
Nature |
High |
21685886
|
| 2013 |
MCU encodes the pore-forming subunit of the mitochondrial Ca2+ uniporter channel. RNAi-mediated knockdown of MCU reduces mitochondrial Ca2+ current (IMiCa) and overexpression increases it. A point mutation in the putative pore domain abolishes ruthenium red sensitivity without altering current magnitude, establishing MCU as the channel-forming subunit. |
Whole-mitoplast voltage-clamp electrophysiology, RNAi knockdown, overexpression, site-directed mutagenesis |
eLife |
High |
23755363
|
| 2012 |
MICU1 interacts with the pore-forming subunit MCU and functions as a gatekeeper that sets a Ca2+ threshold for mitochondrial Ca2+ uptake without affecting MCU kinetic properties. Loss of MICU1 causes constitutive mitochondrial Ca2+ loading, excessive ROS, and apoptotic sensitivity. |
Co-immunoprecipitation, siRNA knockdown, mitochondrial Ca2+ imaging, cell death assays |
Cell |
High |
23101630
|
| 2017 |
The conserved Cys-97 in human MCU is the only reactive thiol that undergoes S-glutathionylation under oxidative/inflammatory conditions, acting as a redox sensor. MCU oxidation or Cys-97 mutation promotes higher-order MCU oligomer formation, persistent channel activity, increased mitochondrial Ca2+ uptake, elevated mitochondrial ROS, and enhanced Ca2+ overload-induced cell death, largely independently of MCU interactions with its regulatory subunits. |
S-glutathionylation biochemical assay, superresolution imaging, site-directed mutagenesis, mitochondrial Ca2+ current measurements, inflammatory and hypoxia cell models |
Molecular cell |
High |
28262504
|
| 2016 |
MCUR1 functions as a scaffold factor for the MCU complex. MCUR1 binds to both MCU and EMRE; loss of MCUR1 impairs mitochondrial Ca2+ uptake and IMiCa current. The minimal coiled-coil domains of MCU and MCUR1 are necessary for heterooligomeric complex formation. |
Protein binding assays, Co-IP, IMiCa current measurement, MCUR1 knockout in cardiomyocytes and endothelial cells, domain mapping |
Cell reports |
High |
27184846
|
| 2015 |
Mia40/CHCHD4 introduces an intermolecular disulfide bond linking MICU1 and MICU2 in a heterodimer. The MICU1-MICU2 heterodimer binds MCU at low Ca2+ concentrations and dissociates upon high Ca2+, providing a Ca2+-dependent mechanism for gating mitochondrial Ca2+ uptake. |
Mia40 interactome analysis, disulfide bond biochemistry, Co-IP, mitochondrial Ca2+ uptake measurements |
Cell metabolism |
High |
26387864
|
| 2016 |
The m-AAA protease degrades non-assembled EMRE subunits to ensure efficient assembly of gatekeeper subunits (MICU1/MICU2) with MCU. Loss of the m-AAA protease results in accumulation of constitutively active MCU-EMRE channels lacking gatekeeper subunits in neuronal mitochondria, causing mitochondrial Ca2+ overload and neuronal death. |
Neuronal interactome analysis, genetic knockout of m-AAA protease, MCU complex assembly assays, mitochondrial Ca2+ measurements, cell death assays |
Molecular cell |
High |
27642048
|
| 2018 |
MICU1 interacts with the D-ring formed by the DIME motif (selectivity filter) of MCU to control Ca2+ flux and gatekeeping. MICU1 suppresses ruthenium red/Ru360 inhibition of MCU; a DIME-interacting domain (DID) in MICU1 is required for both gatekeeping and cooperative activation of MCU as well as cell survival. |
Site-directed mutagenesis of MCU DIME motif and MICU1 DID, Ca2+ uptake assays, Ru360 inhibition assays, cell survival assays |
Molecular cell |
High |
30454562
|
| 2019 |
The DIME-aspartate of MCU mediates a Ca2+-modulated electrostatic interaction with MICU1, forming a contact interface with a nearby Ser residue at the cytoplasmic entrance of the MCU pore. Two conserved Arg residues in MICU1 contact the DIME-Asp. Perturbing MCU-MICU1 interactions causes unregulated, constitutive Ca2+ flux into mitochondria. |
Mutagenesis screen of MCU DIME residues and MICU1 Arg residues, mitochondrial Ca2+ flux assays |
eLife |
High |
30638448
|
| 2020 |
Cryo-EM structure of an MCU-EMRE complex from Tribolium castaneum at 3.5 Å resolution reveals a tetrameric channel with a single ion pore. EMRE is located at the periphery of the transmembrane domain and associates primarily with the first transmembrane helix of MCU. Ca2+ uptake into proteoliposomes requires both EMRE and cardiolipin. |
Cryo-EM structure determination, proteoliposome reconstitution Ca2+ uptake assay, lipid dependence assays |
Journal of molecular biology |
High |
32841658
|
| 2020 |
EMRE controls MCU activity via its transmembrane helix, while an N-terminal PKP motif strengthens MCU binding. MCU opening requires hydrophobic interactions near the pore's luminal end. A single mutation at this site allows human MCU to transport Ca2+ without EMRE. EMRE may facilitate MCU opening by stabilizing the open state in a conserved gating mechanism present in non-metazoan MCU homologs. |
Site-directed mutagenesis, MCU-EMRE concatemer constructs, Ca2+ uptake assays in cells lacking EMRE/MCU |
Cell reports |
High |
33296646
|
| 2019 |
AMPK translocates to mitochondria during mitosis and phosphorylates MCU in a mitosis-specific manner, activating a rapid mitochondrial Ca2+ transient during cell division. MCU-mediated mitochondrial Ca2+ transients boost mitochondrial respiration to restore energy homeostasis during early mitotic ATP drop. Depletion of MCU causes spindle checkpoint-dependent mitotic delay. |
MCU depletion (RNAi), AMPK mitochondrial translocation imaging, phosphorylation assays, mitochondrial Ca2+ and ATP measurements during mitosis, cell cycle analysis |
Nature cell biology |
High |
30858581
|
| 2019 |
MCU Cys-97 (N-terminal domain) is the target site of the cell-permeable MCU inhibitor Ru265. Site-directed mutagenesis of Cys-97 ablates Ru265 inhibitory activity. |
Site-directed mutagenesis, cell-based Ca2+ uptake assays, dose-response inhibition studies |
ACS central science |
High |
30693334
|
| 2017 |
Tissue-specific stoichiometry of MICU1:MCU protein ratio controls the Ca2+ threshold and cooperativity of uniporter activation. Low MICU1:MCU ratio (heart, skeletal muscle) lowers the Ca2+ threshold for uptake; overexpression of MICU1 in heart increases MICU1:MCU ratio, causing liver-like mitochondrial Ca2+ uptake and cardiac contractile dysfunction. |
Quantitative protein ratio analysis, MICU1 pulldown proportional to overexpression, cardiac-specific MICU1 overexpression mouse model, Ca2+ uptake and contractile function measurements |
Cell reports |
High |
28273446
|
| 2017 |
SLC25A23 interacts with MCU (CCDC109A) and MICU1, and increases IMiCa current. SLC25A23 EF-hand domain is required for this function; EF-hand mutants act as dominant negatives reducing mitochondrial Ca2+ uptake. |
Co-IP, IMiCa electrophysiology, RNAi knockdown, dominant-negative EF-hand mutant expression, mitochondrial Ca2+ imaging |
Molecular biology of the cell |
Medium |
24430870
|
| 2017 |
Mitoxantrone is identified as a direct selective inhibitor of human MCU, validated in a reconstituted yeast system expressing human MCU and EMRE and in mammalian cell-based assays. |
High-throughput chemical screen using reconstituted yeast mitochondria with human MCU/EMRE and aequorin, mammalian cell Ca2+ uptake validation |
Molecular cell |
High |
28820965
|
| 2015 |
Cytoplasmic Ca2+ elevation rearranges MICU1 multimers (EC50 ~4.4 µM), activating MCU/EMRE-dependent mitochondrial Ca2+ uptake. This rearrangement requires EF-hand motifs and is independent of matrix Ca2+ concentration, mitochondrial membrane potential, and MCU/EMRE expression levels. |
Live-cell FRET assay for MICU1 multimer rearrangement, EF-hand mutants, controlled cytosolic Ca2+ manipulation |
Scientific reports |
Medium |
26489515
|
| 2017 |
MICU2 regulates the threshold and gain of MICU1-mediated inhibition and activation of MCU. MICU1 alone can mediate gatekeeping and highly cooperative MCU activation; MICU2 restricts spatial Ca2+ crosstalk between InsP3R and MCU channels by modulating MICU1's regulatory activity. |
Controlled cytoplasmic Ca2+ delivery with simultaneous recording of MCU activity, MICU1/MICU2 expression manipulation |
Cell reports |
Medium |
29241542
|
| 2020 |
MCU channel activity is regulated by coupled Ca2+-sensing mechanisms on both sides of the inner mitochondrial membrane. Ca2+ permeating through the channel pore regulates Ca2+ affinities of inhibitory and activating sensors in the mitochondrial matrix. Ca2+ binding to an inhibitory sensor within the MCU amino terminus closes the channel even when MICU1/2 are Ca2+-bound. Disruption of MICU1/2 interaction with MCU complex disables matrix Ca2+ regulation. |
Electrophysiological recordings of MCU channel activity, controlled Ca2+ delivery on both sides of inner mitochondrial membrane, domain mutagenesis |
Proceedings of the National Academy of Sciences of the United States of America |
High |
32801213
|
| 2020 |
EMRE stoichiometry within the MCU complex controls channel gatekeeping. Most endogenous channels contain two EMRE per four MCU. Increasing EMRE:MCU ratio raises the Ca2+ threshold for channel activation. MCU-EMRE concatemers enforcing 1EMRE:4MCU restore Ca2+ uptake but not full gatekeeping; 4EMRE:4MCU enhances gatekeeping. |
Controlled EMRE:MCU expression ratios, MCU-EMRE concatemers, Ca2+ uptake and gatekeeping assays in cells lacking EMRE and MCU |
iScience |
Medium |
32315830
|
| 2019 |
SPG7 directs the m-AAA protease complex to associate with MCU and controls MCU processing, which regulates higher-order MCU complex formation. Loss of SPG7 decreases functional uniporter complex formation, reducing mitochondrial Ca2+ concentration and conferring resistance to Ca2+-induced mPTP opening independent of cyclophilin D. |
SPG7 knockout, MCU complex assembly analysis, mitochondrial Ca2+ measurements, mPTP opening assays |
The Journal of biological chemistry |
Medium |
31097542
|
| 2015 |
Ca2+ signals regulate MCU gene expression through CREB-mediated transcription. CREB directly binds the MCU promoter and stimulates its expression in response to cytoplasmic Ca2+ signals generated by IP3R, STIM1, and Orai1. Loss of these Ca2+ entry pathways reduces MCU abundance and mitochondrial Ca2+ uptake capacity. |
Chromatin immunoprecipitation (ChIP), promoter reporter assay, genetic deletion of IP3R/STIM1/Orai1 in DT40 B cells, MCU abundance measurements |
Science signaling |
High |
25737585
|
| 2022 |
CaMKIIδB phosphorylates CREB, which binds the MCU promoter to upregulate Mcu gene transcription in cardiomyocytes. Isoproterenol-induced β-adrenergic stimulation upregulates MCU through the β-AR/CaMKIIδB/CREB pathway. Calcineurin-mediated dephosphorylation at Ser332 promotes nuclear translocation of CaMKIIδB to execute this transcriptional regulation. |
MCU KO and cardiac-specific MCU overexpression mouse models, adenoviral gene manipulation, CREB phosphorylation and promoter binding assays, intracellular Ca2+ handling measurements |
Circulation |
High |
35167328
|
| 2013 |
MCU is mitochondrially localized and its expression is subject to activity-dependent transcriptional regulation in neurons. Synaptic activity transcriptionally represses Mcu via nuclear Ca2+ and CaM kinase-mediated induction of Npas4, reducing NMDA receptor-induced mitochondrial Ca2+ uptake and protecting against excitotoxic death. |
Exogenous MCU expression with mitochondrial localization imaging, MCU knockdown, NMDA stimulation, Ca2+ and cell death assays, Npas4-dependent transcriptional repression assay |
Nature communications |
High |
23774321
|
| 2018 |
RIPK1 physically interacts with MCU to promote mitochondrial Ca2+ uptake and energy metabolism, driving colorectal cancer cell proliferation. The ubiquitination site RIPK1-K377 is critical for MCU interaction. |
Co-immunoprecipitation, RIPK1 overexpression and knockdown, mitochondrial Ca2+ measurement, proliferation assays, domain mutant analysis |
Cancer research |
Medium |
29531160
|
| 2018 |
MCU interacts with Miro1 through MCU's N-terminal domain, which traverses the outer mitochondrial membrane. This MCU-Miro1 interaction is required for Miro1-directed mitochondrial movement in neurons. The N-terminus is dispensable for MCU mitochondrial targeting but critical for Miro1 interaction. |
Co-immunoprecipitation, domain deletion/mutation analysis, mitochondrial localization imaging, mitochondrial movement assays in neurons |
The Journal of neuroscience |
Medium |
29686046
|
| 2019 |
MCU deletion in mouse liver (MCUΔhep) inhibits mitochondrial Ca2+ uptake, delays cytosolic Ca2+ clearance, reduces oxidative phosphorylation, and causes hepatic lipid accumulation. This is mediated by extramitochondrial Ca2+-dependent protein phosphatase-4 (PP4) activity that dephosphorylates and inactivates AMPK. PP4 knockdown or AMPK reconstitution reverses lipid accumulation; gain-of-function MCU decreases PP4 and reduces lipid accumulation. |
Liver-specific Mcu gene deletion (CRISPR/Cas9 in zebrafish, Cre-lox in mice), PP4 activity assay, AMPK phosphorylation analysis, lipid quantification, reconstitution experiments |
Cell reports |
High |
30917323
|
| 2019 |
Loss of MCU prevents mitochondrial fusion during G1-S phase and blocks cell cycle progression and proliferation. MCU-null cells show baseline CaMKII activation, increased Drp1 Ser616 phosphorylation, mitochondrial fragmentation, and impaired respiration. Inhibition of cytosolic CaMKII or mitochondrial fission rescues these defects, revealing a regulatory circuit between MCU, cytosolic CaMKII, and Drp1-mediated fission/fusion. |
MCU genetic deletion, cell cycle analysis, CaMKII and Drp1 phosphorylation assays, mitochondrial fusion/fission imaging, MCU rescue experiments |
Science signaling |
High |
31040260
|
| 2016 |
Crystal structure of CCDC90B (paralog of MCUR1) head domain reveals a conserved head-neck-stalk-anchor architecture. The head domain of MCUR1 directly interacts with MCU and is destabilized upon Ca2+ binding, providing structural details for MCU-MCUR1 complex formation. |
Crystal structure determination, protein binding assay, Ca2+ interaction analysis |
Structure |
Medium |
30612859
|
| 2014 |
MCU interacts with VDAC1; MCU mediates VDAC1 overexpression-induced cell death in cerebellar granule neurons. MCU-VDAC1 complex regulates mitochondrial Ca2+ uptake and oxidative stress-induced apoptosis. |
Co-immunoprecipitation, MCU knockdown, mitochondrial Ca2+ imaging, cell death assays |
Protein & cell |
Low |
25753332
|
| 2018 |
STAT3 (phospho-STAT3ser727) co-localizes and interacts with the N-terminal domain (NTD) of MCU in cardiomyocytes treated with moderate H2O2 postconditioning, inhibiting MCU opening and alleviating mitochondrial Ca2+ overload during ischemia-reperfusion. |
Co-localization/co-immunoprecipitation, STAT3 overexpression/shRNA, NTD domain-specific interaction mapping, mitochondrial Ca2+ measurements, cardiomyocyte I/R model |
Basic research in cardiology |
Medium |
31463567
|
| 2021 |
HINT2 directly interacts with MCU and suppresses MCU complex activation, thereby reducing mitochondrial Ca2+ overload in cardiac microvascular endothelial cells. HINT2 overexpression inhibits the MCU complex-mitochondrial Ca2+ overload-mitochondrial fission-apoptosis pathway; re-activation of MCU by spermine abolishes HINT2 protection. |
Co-immunoprecipitation, HINT2 overexpression, mitochondrial Ca2+ measurement, MCU agonist (spermine) rescue experiment, in vivo I/R model |
Basic research in cardiology |
Medium |
34914018
|
| 2017 |
MCU-dependent mitochondrial Ca2+ uptake promotes ROS production by downregulating NAD+/NADH ratio and inhibiting SIRT3 deacetylase activity, thereby inhibiting SOD2 activity. This leads to ROS-activated JNK pathway and MMP-2 activation promoting cancer cell migration and metastasis. |
MCU overexpression/knockdown, mitochondrial Ca2+ imaging, NAD+/NADH ratio measurement, SIRT3 activity assay, SOD2 activity assay, JNK phosphorylation, invasion/migration assays, xenograft model |
Oncogene |
Medium |
28650465
|
| 2020 |
MCU-induced mitochondrial Ca2+ uptake inhibits phosphorylation of TFAM, enhancing its stability and promoting mitochondrial biogenesis, which increases mitochondrial ROS and activates NF-κB signaling to promote colorectal cancer cell growth. |
MCU overexpression/knockdown, TFAM phosphorylation assays, mitochondrial biogenesis markers, ROS measurement, NF-κB activation, xenograft model |
Signal transduction and targeted therapy |
Medium |
32371956
|
| 2020 |
Inhibition of mitochondrial pyruvate transport or fatty acid flux triggers EGR1-mediated upregulation of MICU1 (not MCU core subunit), inhibiting MCU-mediated mitochondrial Ca2+ uptake. This reveals a TCA substrate-availability feedback circuit protecting cells from bioenergetic crisis and Ca2+ overload during nutrient stress. |
MPC isoform knockdown, dominant-negative MPC1R97W, MPC1 genetic ablation in hepatocytes and MEFs, MICU1 protein abundance assays, EGR1 transcription factor identification, mitochondrial Ca2+ measurements |
Science signaling |
Medium |
32317369
|
| 2018 |
Parkin (PARK2) interacts with MICU1 (an MCU complex regulator) and promotes its proteasomal degradation via the UPS. Parkin's Ubl domain, but not its E3-ubiquitin ligase activity, is required for MICU1 degradation. Loss of Parkin function impairs mitochondrial Ca2+ handling. |
Co-immunoprecipitation, UPS inhibitor treatment, Parkin domain mutants, MICU1 stability assays, mitochondrial Ca2+ measurements |
Scientific reports |
Medium |
30242232
|
| 2018 |
MICU1 confers protection from MCU-dependent manganese toxicity. Reconstitution of MCU and EMRE in yeast enhances manganese stress; co-expression of MICU1 prevents this. In human cells, MICU1 deletion sensitizes cells to manganese-dependent cell death by disinhibiting MCU-mediated manganese uptake, causing oxidative stress preventable by NAC. |
Synthetic biology reconstitution in yeast, MICU1 deletion in human cells, manganese stress assays, oxidative stress measurement |
Cell reports |
High |
30403999
|
| 2019 |
Pyk2 directly phosphorylates MCU to enhance mitochondrial Ca2+ uptake in neurons. The Pyk2/MCU pathway is activated in rat cerebral ischemia, causing mitochondrial dysfunction and neuronal apoptosis. Pyk2 inhibitor (PF-431396) prevents MCU-dependent mitochondrial Ca2+ overload and cell death. |
Rat MCAO ischemia model, Pyk2 inhibitor treatment, mitochondrial Ca2+ measurement, mitochondrial dysfunction and apoptosis assays |
Neuroscience research |
Low |
28916471
|
| 2023 |
MARS2 (mitochondrial methionyl-tRNA synthetase) interacts with MCU and stimulates mitochondrial Ca2+ influx. Methionine binding to MARS2 acts as a molecular switch regulating the MARS2-MCU interaction. Knockdown of MARS2 attenuates mitochondrial Ca2+ influx and induces downstream CaMKII/CREB signaling and metabolic rewiring. |
Co-immunoprecipitation, MARS2 knockdown, mitochondrial Ca2+ measurement, Ca2+-dependent signaling assays |
Redox biology |
Medium |
36774778
|
| 2023 |
MCU activates mitochondrial respiration and net reduction of mitochondrial (but not cytosolic) redox state. MCU stimulation modulates redox-sensitive groups required for maintaining respiratory capacity in human myotubes and C. elegans. This redox modulation promotes mobility in worms. |
Mitochondria-targeted redox and calcium sensors, MCU genetic ablation models in human myotubes and C. elegans, direct pharmacological mitochondrial protein reduction |
Redox biology |
Medium |
37302345
|
| 2023 |
Cd upregulates MCU expression through CREB phosphorylation at Ser133 binding to the MCU promoter (at TGAGGTCT, ACGTCA, and CTCCGTGATGTA regions). Upregulated MCU intensively interacts with VDAC1, enhances VDAC1 dimerization and ubiquitination, resulting in excessive mitophagy and hepatotoxicity. |
CREB phosphorylation assay, MCU promoter ChIP/reporter analysis, Co-IP for MCU-VDAC1, VDAC1 ubiquitination assay, MCU siRNA/Ru360, heterozygous MCU KO mice |
Advanced science |
Medium |
36642847
|
| 2014 |
ERp57 regulates the expression of MCU and modulates mitochondrial Ca2+ uptake. Silencing ERp57 downregulates MCU protein level and inhibits mitochondrial Ca2+ uptake; re-expression of MCU in ERp57-knockdown cells restores mitochondrial Ca2+ uptake. |
ERp57 siRNA knockdown, MCU expression measurement, mitochondrial Ca2+ uptake assay, MCU rescue experiment |
FEBS letters |
Low |
24815697
|
| 2020 |
In beta cell-specific Mcu-null mice, glucose-stimulated mitochondrial Ca2+ accumulation, ATP production, and insulin secretion are strongly inhibited. MCU deletion increases cytosolic Ca2+ concentration and improves mitochondrial membrane depolarization. MCU is thus required for normal glucose-stimulated insulin secretion in vivo. |
Beta cell-specific Mcu KO (Ins1Cre), live fluorescence Ca2+ and ATP imaging, patch-clamp electrophysiology, in vivo glucose tolerance tests |
Diabetologia |
High |
32350566
|
| 2021 |
In MCU-KO hearts, no alternative Ca2+ uptake mechanisms are detected, confirming MCU is the sole route for mitochondrial Ca2+ entry under the conditions tested. |
Optical mitochondrial Ca2+ measurement in intact perfused MCU-KO hearts, adrenergic stimulation |
Cell reports |
Medium |
34686324
|
| 2024 |
In Duchenne muscular dystrophy mitochondria, an MCU-independent Ca2+ uptake mechanism exists that is sufficient to drive mitochondrial permeability transition pore activation and skeletal muscle necrosis. Myofiber-specific Mcu gene deletion was not protective and did not prevent mitochondrial Ca2+ overload in this disease model. |
Myofiber-specific Mcu gene deletion, Mcub gene deletion, mitochondrial Ca2+ measurement, muscle histopathology, muscle function tests |
Scientific reports |
Medium |
38514795
|
| 2022 |
Cardiolipin (CL) is required for the abundance and stability of the MCU complex regulatory subunit MICU1, but not for MCU itself. In Barth syndrome (CL deficiency), reduced MICU1 perturbs the kinetics of MICU1-dependent mitochondrial Ca2+ uptake and impairs pyruvate dehydrogenase activation and mitochondrial bioenergetics. |
Multiple BTHS models (yeast, mouse myoblasts, patient cells/cardiac tissue), MICU1 stability assays, MCU/MICU1/MICU2/EMRE/MCUR1 abundance measurements, mitochondrial Ca2+ uptake kinetics, PDH activation assay |
Human molecular genetics |
Medium |
34494107
|